TrialVaccine2015

A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants.

M Tameris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.